RayzeBio, Inc.
Indiana
Works in Dermatology · GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory
RayzeBio, Inc. is a clinical trial sponsor based in Indiana. It has 8 active clinical trials with 1,288 planned participants, across 6 therapeutic areas. Its FDA record on file shows compliance actions.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about RayzeBio, Inc
No warning letter naming RayzeBio, Inc is on file. FDA has published other compliance actions naming it.
RayzeBio, Inc is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 1,288 planned participants, in Dermatology, GI & liver, Metabolic & endocrine, Oncology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
RayzeBio, Inc is based in Indiana. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with RayzeBio, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with RayzeBio, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.